mv1lu cells (ATCC)
Structured Review

Mv1lu Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 520 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mv1lu+cells/Mv+1+Lu/pmc12671118-133-0-2
Average 95 stars, based on 520 article reviews
Images
1) Product Images from "Development of cell combos micromethod to isolate respiratory viruses not detected by molecular techniques"
Article Title: Development of cell combos micromethod to isolate respiratory viruses not detected by molecular techniques
Journal: Microbiology Spectrum
doi: 10.1128/spectrum.02571-25
Figure Legend Snippet: Images of cellular mats taken with an Evos FL digital inverted fluorescence microscope. ( A ) MNT1; ( B ) A549; ( C ) combo MNT1/H292; ( D ) Mv1Lu; ( E ) A549; ( F ) combo Mv1Lu/A549; ( G ) Ve6TMPRSS2; ( H ) MDCK; ( I ) ccombo Ve6TMPRSS2/MDCK; ( J ) Caco-2; ( K ) MRC5; ( L ) combo Caco-2/MRC5; ( M ) BHK-21; ( N ) L929; ( O ) combo BHK-21/L929. Pictures are taken at magnification ×20; scale bars indicate 400 µm.
Techniques Used: Fluorescence, Microscopy
Figure Legend Snippet: Examples of cytopathic effects with various viruses on each cell combo developed. ( A ) MNT1/H292 negative control, ( B ) HCoV-OC43 on MNT1/H292, ( C ) Mv1Lu/A549 negative control, ( D ) HRSV-B on Mv1Lu/A549, ( E ) Ve6TMPRSS2/MDCK negative control, ( F ) HPIV-1 on Ve6TMPRSS2/MDCK, ( G ) Caco-2/MRC5 negative control, ( H ) HCoV-229E on Caco-2/MRC5, ( I ) BHK-21/L929 negative control, ( J ) adenovirus on BHK-21/L929. Pictures are taken at magnification ×10; scale bars indicate 400 µm.
Techniques Used: Negative Control
Figure Legend Snippet: Respiratory virus growths on each cell combo developed. ( A ) Combo MNT1/H292; ( B ) combo Mv1Lu/A549; ( C ) combo VE6TMPRSS2/MDCK; ( D ) combo Caco-2/MRC5; ( E ) combo BHK21/L929. Dashed line indicates significant growth (3.3 Ct that is a proxy of a 1.0 log 10 variation). Ct, real-time PCR cycle threshold value; HCoV, human coronavirus; HPIV, human parainfluenza virus; HRSV, human respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Techniques Used: Virus, Real-time Polymerase Chain Reaction
Related Articles
other:Article Title: Development of cell combos micromethod to isolate respiratory viruses not detected by molecular techniques Article Snippet: Article Title: Development of cell combos micromethod to isolate respiratory viruses not detected by molecular techniques. Article Snippet: Article Title: Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation. Article Snippet: Generated:Article Title: Continuous In-Line Virus Inactivation for Next Generation Bioprocessing. Article Snippet: 1 Research Article Continuous In-Line Virus Inactivation for Next Generation Bioprocessing† Christopher Gillespie1 Melissa Holstein1 Lori Mullin1 Kristen Cotoni1 Ronald Tuccelli1 John Caulmare1 Patricia Greenhalgh1 1MilliporeSigma, Bedford, MA, USA Correspondence: Christopher Gillespie, Process Solutions, MilliporeSigma, 80 Ashby Road, Bedford, MA 01730, United States.. E-mail: christopher.gillespie@emdmillipore.com Modification:Article Title: Continuous In-Line Virus Inactivation for Next Generation Bioprocessing. Article Snippet: 1 Research Article Continuous In-Line Virus Inactivation for Next Generation Bioprocessing† Christopher Gillespie1 Melissa Holstein1 Lori Mullin1 Kristen Cotoni1 Ronald Tuccelli1 John Caulmare1 Patricia Greenhalgh1 1MilliporeSigma, Bedford, MA, USA Correspondence: Christopher Gillespie, Process Solutions, MilliporeSigma, 80 Ashby Road, Bedford, MA 01730, United States.. E-mail: christopher.gillespie@emdmillipore.com Incubation:Article Title: Demonstrating the Effectiveness of an Alternative to Triton X-100 for Detergent-Mediated Viral Inactivation in Biomanufacturing. Article Snippet: Detergent‐mediated viral inactivation is an important process step for ensuring viral safety of parenteral biotherapeutics, including plasma proteins and monoclonal antibodies (mAb).. The conventional Triton X‐100 detergent has ecological toxicity concerns and REACH classification that mandate replacement in the biopharmaceutical industry.. Criteria for a replacement detergent include viral inactivation efficacy, acceptable safety and biodegradation profile, process removal, and quality suitable for parenteral drug product manufacturing. Cell Culture:Article Title: Demonstrating the Effectiveness of an Alternative to Triton X-100 for Detergent-Mediated Viral Inactivation in Biomanufacturing. Article Snippet: Detergent‐mediated viral inactivation is an important process step for ensuring viral safety of parenteral biotherapeutics, including plasma proteins and monoclonal antibodies (mAb).. The conventional Triton X‐100 detergent has ecological toxicity concerns and REACH classification that mandate replacement in the biopharmaceutical industry.. Criteria for a replacement detergent include viral inactivation efficacy, acceptable safety and biodegradation profile, process removal, and quality suitable for parenteral drug product manufacturing. |
